CoreValve Evolut
Device Transcatheter Valve Systems
General payments
$13,208,771
Research payments
$20,228,466
Through program year 2020, $13,208,771 in general payments and $20,228,466 in research payments were reported against CoreValve Evolut (Transcatheter Valve Systems).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $5,081,297 | 15,003 |
| 2020 | Research | $7,156,603 | 1,661 |
| 2019 | General | $8,127,475 | 22,030 |
| 2019 | Research | $13,071,863 | 2,012 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 54 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
37,033 general · 3,673 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.